Evolution is often characterized as a process involving incremental genetic changes that are slowly discovered and fixed in a population through genetic drift and selection. However, a growing body of evidence is finding that changes in the environment frequently induce adaptations that are much too rapid to occur by an incremental genetic search process. Rapid evolution is hypothesized to be facilitated by mutations present within the population that are silent or "cryptic" within the first environment but are co-opted or "exapted" to the new environment, providing a selective advantage once revealed. Although cryptic mutations have recently been shown to facilitate evolution in RNA enzymes, their role in the evolution of complex phenotypes has not been proven. In support of this wider role, this paper describes an unambiguous relationship between cryptic genetic variation and complex phenotypic responses within the immune system. By reviewing the biology of the adaptive immune system through the lens of evolution, we show that T cell adaptive immunity constitutes an exemplary model system where cryptic alleles drive rapid adaptation of complex traits. In naive T cells, normally cryptic differences in T cell receptor reveal diversity in activation responses when the cellular population is presented with a novel environment during infection. We summarize how the adaptive immune response presents a well studied and appropriate experimental system that can be used to confirm and expand upon theoretical evolutionary models describing how seemingly small and innocuous mutations can drive rapid cellular evolution.
Evolution is often characterized as a process involving incremental genetic changes that are slowly discovered and fixed in a population through genetic drift and selection. However, a growing body of evidence is finding that changes in the environment frequently induce adaptations that are much too rapid to occur by an incremental genetic search process. Rapid evolution is hypothesized to be facilitated by mutations present within the population that are silent or "cryptic" within the first environment but are co-opted or "exapted" to the new environment, providing a selective advantage once revealed. Although cryptic mutations have recently been shown to facilitate evolution in RNA enzymes, their role in the evolution of complex phenotypes has not been proven. In support of this wider role, this paper describes an unambiguous relationship between cryptic genetic variation and complex phenotypic responses within the immune system. By reviewing the biology of the adaptive immune system through the lens of evolution, we show that T cell adaptive immunity constitutes an exemplary model system where cryptic alleles drive rapid adaptation of complex traits. In naive T cells, normally cryptic differences in T cell receptor reveal diversity in activation responses when the cellular population is presented with a novel environment during infection. We summarize how the adaptive immune response presents a well studied and appropriate experimental system that can be used to confirm and expand upon theoretical evolutionary models describing how seemingly small and innocuous mutations can drive rapid cellular evolution.
Introduction: The Role of Cryptic Genetic Variation in Evolution
Cryptic genetic variation (CGV) describes genetic diversity that is hidden within populations that occupy their native habitats but that is revealed as trait diversity within new environments (Gibson and Dworkin, 2004; Le Rouzic and Carlborg, 2008; Schlichting, 2008; McGuigan and Sgrò, 2009). CGV has been revealed in populations through changes in pH, temperature, nutrient concentrations, moisture, salinity, oxygen, altitude, habitat, and hormone levels. In Drosophila melanogaster, the presence of cross veins in wings, wing shape, scutellar bristle number, and the patterning of photoreceptors in the eye are each highly polygenic traits with little variation in native environments but considerable variation under modified environmental conditions.Cryptic genetic variation is of considerable scientific interest due to its potential contribution to evolution (see Cryptic Genetic Variation and Evolution in Appendix) and particularly for rapid evolutionary responses to changing environments. Rapid evolution – evolutionary change that is orders of magnitude faster than expected based on inferences from the fossil record – has been reported in dozens of species where local populations are presented with novel environments (Hendry and Kinnison, 1999; Kinnison and Hendry, 2001; Reznick and Ghalambor, 2001). Rapid evolution is unlikely to be driven by de novo mutations due to the relatively slow pace that new genotypes can be discovered and fixed in a population. On the other hand, standing genetic variation is more likely to support rapid evolution in novel environments because it is available immediately at the time that selection changes and because multiple copies of a beneficial allele may already exist thereby increasing both the speed and likelihood of fixation (Barrett and Schluter, 2008). Because cryptic genetic variation is selectively neutral in the original environment, it can accumulate and be maintained, while its release of heritable trait diversity could provide fuel for rapid evolutionary responses to environmental change.In line with this paradigm, a recent study by Wagner and colleagues, using a ribozyme RNA enzyme as their experimental model, confirmed that ribozyme populations containing cryptic variation more rapidly adapted to new substrates compared to ribozyme populations that did not contain cryptic mutations (Hayden et al., 2011). This study provides the first direct experimental confirmation that cryptic genetic changes can promote rapid evolution. While additional studies strongly implicate CGV in the rapid evolution of complex phenotypes (for example see Palmer, 2004; McGuigan et al., 2011), a direct connection between cryptic alleles and novel traits has not been confirmed in other studies. Directly demonstrating the contribution of CGV in rapid evolution of a complex organism remains a challenging milestone (McGuigan and Sgrò, 2009), in part because genetic diversity can be distributed over a large genome, traits can have a large but unknown genetic footprint, and several factors such as mutations, stochastic effects, and environmental heterogeneity can influence allele frequencies and confound links between CGV and adaptation.To formally confirm the role of cryptic variation in the evolution of complex phenotypes it is essential to identify model systems where specific and well-characterized cryptic alleles can be shown to drive trait differences with adaptive significance in new environments. In this review we explain how the adaptive immune response of T cells provides an ideal model system that clearly demonstrates the potentially important relationship between CGV and rapid evolution.
The Adaptive Immune System: A Primer
The adaptive immune system provides vertebrates with the ability to recognize and respond to a variety of pathogens including parasites, bacteria, fungi, and viruses. The primary effector cells of the adaptive immune system are B cells and T cells, which are derived from the same multi-potent hematopoietic stem cells. B cells mature in the bone marrow and are involved primarily in the creation of antibodies. B cells express the B cell receptor (BCR), which is a membrane-bound antibody molecule. Different BCRs recognize and bind to their respective foreign molecules (antigens). Once a B cell binds its cognate antigen and receives an additional signal from a helper T cell, it activates proximal signaling events triggering its differentiation into a short lived effector plasma cell that functions to secrete antibodies (soluble forms of the BCR) that bind to its cognate antigen. Antibodies bound to foreign molecules make them easy targets for phagocytosis and other clearance mechanisms. Sub-populations of activated B cells differentiate into long-lived antigen-specific memory B cells, which remain in circulation and can respond quickly if the host is re-infected by the same pathogen.T cells mature in the thymus and are involved primarily in cell-mediated immune responses. They differ from B cells in that their antigen binding receptor, known as the T cell receptor (TCR) can only recognize peptide antigens that have been proteolytically cleaved and presented in the context of a host cell major histocompatibility complex (MHC) protein (Figure A2 in Appendix). All nucleated cells are capable of expressing antigen in an MHC class I complex and activating a T cell response. However B cells, dendritic cells, and macrophages additionally express MHC class II molecules, as well as other immune-stimulatory molecules, that allow enhanced activation of T cells, and are classified as professional antigen-presenting cells (APCs).
Figure A2
T cell activation. The TCR complex (TCR α and β chains and CD3) and the co-receptors CD4 or CD8 are associated with tyrosine kinases of the Src family. When the TCR binds to an MHC presenting its cognate antigen, the co-receptors CD4/CD8 also bind the MHC molecule on the APC surface. The dephosphorylation of Src kinases by the phosphatase CD45 leads to their activation, and the Src kinases phosphorylate ITAMs within the receptor complex (red circles). ITAM phosphorylation then leads to the recruitment and activation of the kinase Zap70 and the subsequent recruitment of multiple other signaling molecules. One crucial event is activation of the enzyme phospholipase C γ-1, leading to activation of the three main signaling pathways that drive T-cell activation, the Ras-MAP kinase Pathway, the protein kinase C pathway, and calcineurin pathway. These pathways culminate in the activation of the transcription factors NF-κB, NFAT, and AP-1, initiating gene transcription and resulting in the differentiation, proliferation, and effector activity of T-cells.
There are two primary types of T cells, cytotoxic T cells (CTLs), and helper T cells. Naive CTLs are activated when they recognize their cognate antigenic peptide presented in the context of an infected host cell’s MHC class I molecule. Once activated, the CTL undergoes clonal expansion where it simultaneously differentiates into a mature CTL and divides rapidly, generating a large number of activated effector cells that travel through the body and scan for infected cells expressing the same antigenic peptide. Active CTLs induce lysis and apoptosis in infected cells. Most effector CTLs undergo apoptosis and are cleared away by phagocytic cells once the infection is resolved, however a subset of CTLs differentiate into memory cells that can rapidly respond to subsequent infections by the same pathogen. Helper T cells have no cytotoxic activity, and instead function to regulate the adaptive immune response. The TCR of T helper cells recognize antigen peptide bound to class II MHC molecules on the host cell surface. The activation of naive T helper cells results in differentiation and clonal expansion similar to CTLs. Unlike CTLs, activation of helper T cells triggers them to release cytokines that regulate the activity of many types of cells including APCs, B cells, and CTLs.Together, the components of the adaptive immune system respond rapidly and specifically to infection from previously un-exposed pathogens (Raff, 1973). Importantly, in most cases, during subsequent exposure to the same pathogen, the memory response is so protective that no outward signs of re-exposure may be seen (Sallusto et al., 2004). Although many of the characteristics of the adaptive immune response were demonstrated decades ago (North, 1969; Paul and Benacerraf, 1977), the elegance and efficiency of antigen recognition was not fully appreciated until the genetic and molecular basis of this response was determined (Rajewsky, 1996).
The Immunological Role of the T Cell Receptor
Under conditions where foreign proteins are present, such as during a viral infection or phagocytosis of a pathogen, foreign peptides become available to be processed and loaded onto MHC molecules. It is the replacement of a proportion of endogenous self-peptides by foreign peptides that activates the T cells in the periphery. T cell activation involves an elaborate series of events between the T cell and the MHC-expressing APC (Summary of T Cell Selection in the Thymus in Appendix). Several receptor–ligand interactions between T cells and APCs are important for activation, however activation differences between T cells are determined by whether TCR recognizes the foreign peptide loaded onto the MHC molecule. Interestingly, T cell activation has been shown to be digital in nature: a T cell can only exist in an “Off” (resting) state or an “On” (activated) state (Altan-Bonnet and Germain, 2005; Daniels et al., 2006; Chakraborty et al., 2009; Das et al., 2009; Lin et al., 2009; Prasad et al., 2009). This means that as long as the threshold of activation is achieved, relatively weak stimuli (low affinity) will induce the same response as strong stimuli (high affinity) at the single cell level. In other words, selectively relevant trait differences in T cells can be captured by a single binary variable (Altan-Bonnet and Germain, 2005; Chakraborty et al., 2009). Although there are some differences in how activation takes place for different classes of T cells and the different types of MHC molecules, TCR recognition of the peptide loaded MHC remains the defining step in all cases of T cell activation.
The genetic basis of the TCR repertoire
The development of a diverse T cell repertoire is a critical step for maintaining the overall health of an organism as it allows the adaptive immune system to respond to many different pathogenic antigens. Genetic variation of the TCR across the T cell population provides the requisite variety of cell response options that is necessary for the adaptive immune response. These genetic differences among T cells arise through the stochastic recombination of a diverse set of gene segments that make up the TCR. The TCR itself is composed of several subunits ultimately expressed on the surface of the cell. The α and β chains of the TCR are directly responsible for ligand recognition and therefore represent the variable and unique portion of each TCR complex that interacts with peptide–MHC complexes. The other subunits that comprise the TCR (collectively called CD3 chains) are non-variable and are responsible for propagating signals in the cytoplasm of the cell. These signaling subunits contain highly conserved motifs that are critical for initiating the intracellular events leading to T cell activation.T cell development begins with the entry of T cell progenitors into the thymus, which initiates a program of differentiation that includes TCR gene re-arrangement and expression (Figure 1 and Summary of T Cell Selection in the Thymus in Appendix). The variability of each α and β chain is generated by the random selection and imprecise joining of different germline encoded gene segments (Schatz, 2004). The recombination of these gene segments also involves the addition of random nucleotides at each gene segment junction further increasing the variability seen in TCR repertoires. The α and β chains, if recombined successfully, are then co-expressed and assembled with the CD3 chains to form a TCR with specificity that is unique to that cell. Studies have suggested that this mechanism can potentially generate 1012–1015 different possible TCRs (Davis and Bjorkman, 1988). The stochastic generation of the TCR by recombination thus constitutes a large, pre-established genotype space for TCR and along with its associated antigenic specificity provides a relatively simple and well-defined fitness landscape of T cell activation.
Figure 1
Thymic selection of T cells. (A) Immature T cells (called thymocytes) enter the thymic cortex and, supported by factors secreted by cortical thymic epithelial cells (cTECs, green), undergo differentiation. During this time TCR re-arrangement occurs until an active TCR is expressed along with both the CD4 and CD8 co-receptors (double positive/DP stage). Those DP thymocytes that have a functional TCR and survive commit to a single positive (SP) state (SP thymocytes express either CD4 or CD8, but not both) and migrate to the thymic medulla. Here, SP thymocytes systematically scan medullary thymic epithelial cells (mTECs, shown in brown) and dendritic cells presenting self-peptides in their MHC molecules. During the SP thymocyte stage, any thymocyte that expresses a TCR that has an above threshold affinity to self-peptides undergoes apoptosis and dies. Surviving thymocytes eventually exit the thymus and enter the periphery as mature, naïve T cells. (B) Positive and negative selection is determined by TCR affinity to their peptide/MHC ligand. Once a TCR is expressed on the cell surface it immediately begins interacting with MHC molecules presenting self-peptides. Functional TCR’s generate a basal signal output that, although insufficient to cross the activation threshold, is still necessary for thymocyte survival. TCR’s that cannot recognize peptide/MHC complexes ultimately die by neglect. Surviving thymocytes then migrate to the thymic medulla where they are exposed to self antigen through promiscuous gene expression in mTECs and DCs. Any TCR that reacts with a self-peptide with too high of an affinity will induce T cell activation and apoptosis. Only thymocytes with a functional TCR, which is competent to trigger low-level signaling but does not cross the activation threshold to self-peptides, is positively selected and permitted to exit the thymus.
Thymic selection of T cells. (A) Immature T cells (called thymocytes) enter the thymic cortex and, supported by factors secreted by cortical thymic epithelial cells (cTECs, green), undergo differentiation. During this time TCR re-arrangement occurs until an active TCR is expressed along with both the CD4 and CD8 co-receptors (double positive/DP stage). Those DP thymocytes that have a functional TCR and survive commit to a single positive (SP) state (SP thymocytes express either CD4 or CD8, but not both) and migrate to the thymic medulla. Here, SP thymocytes systematically scan medullary thymic epithelial cells (mTECs, shown in brown) and dendritic cells presenting self-peptides in their MHC molecules. During the SP thymocyte stage, any thymocyte that expresses a TCR that has an above threshold affinity to self-peptides undergoes apoptosis and dies. Surviving thymocytes eventually exit the thymus and enter the periphery as mature, naïve T cells. (B) Positive and negative selection is determined by TCR affinity to their peptide/MHC ligand. Once a TCR is expressed on the cell surface it immediately begins interacting with MHC molecules presenting self-peptides. Functional TCR’s generate a basal signal output that, although insufficient to cross the activation threshold, is still necessary for thymocyte survival. TCR’s that cannot recognize peptide/MHC complexes ultimately die by neglect. Surviving thymocytes then migrate to the thymic medulla where they are exposed to self antigen through promiscuous gene expression in mTECs and DCs. Any TCR that reacts with a self-peptide with too high of an affinity will induce T cell activation and apoptosis. Only thymocytes with a functional TCR, which is competent to trigger low-level signaling but does not cross the activation threshold to self-peptides, is positively selected and permitted to exit the thymus.
TCR/MHC interactions within the thymus dictate selection of the naïve T cell population
Mature T cells present in the periphery must be able to carefully distinguish between cells presenting harmless endogenous self-peptides and cells presenting foreign peptides derived from potentially dangerous pathogens. Once the TCR has been assembled through stochastic DNA recombination, it is rigorously tested within the thymus to ensure that it is functional but will not respond to self-peptides (Figure 1 and Summary of T Cell Selection in the Thymus in Appendix). Defects in this selection process can lead to either profound immunodeficiencies or debilitating autoimmune diseases. At the heart of this selection process is the determination of how the newly formed TCR interacts with a peptide loaded MHC molecule. First, TCRs are screened for their ability to weakly recognize endogenous “self” peptides displayed on an MHC molecule within the cortex of the thymus (Figure 1 and reviewed in Starr et al., 2003).Those mature T cells that survive thymic selection represent fewer than 5% of the starting pre-selected thymocyte population and are exported from the thymus, entering the circulatory system to ultimately reside in the peripheral lymphoid organs. It is believed that following selection in the thymus, the range of TCR variation is between 106 and 107 (Arstila et al., 1999).
T Cells Provide an Unambiguous Example of Evolution Driven by Environment-Exposed CGV
With evidence of cryptic genetic variants being co-opted into beneficial functions (Waddington, 1942, 1957a; for example through exaptation; Badyaev, 2005), there could potentially be many circumstances where novel environments reveal CGV and drive rapid evolution in natural populations (Palmer, 2004; Hayden et al., 2011; McGuigan et al., 2011). To clearly demonstrate this evolutionary pathway, several conditions must be met. Populations typically must occupy habitats that are stable over many generations (CGV condition 1) and accumulate considerable genetic diversity while exhibiting only small trait differences (CGV condition 2). When presented with novel environments, the same population needs to display new quantitative traits (CGV condition 3) that have a heritable basis (CGV condition 4) and thus may contribute to evolution within the novel environment (Gibson and Dworkin, 2004; Whitacre, 2012).Each of these conditions corresponds with well-characterized features in the adaptive immune system. T cells develop in a stable thymic environment where a sub-population is selected to mature and leave the thymus based on positive/negative selection. To satisfy the selection conditions, TCRs must have an affinity to host cell protein fragments that is strong enough to result in non-trivial adhesion between the T cell and host cell but is not so strong as to elicit T cell activation. The result is a thymic environment that efficiently selects for mature T cells with similar behavior under “normal” conditions that are devoid of foreign antigens. These selection conditions within the thymus are stable and remain the same throughout the lifetime of the organism (CGV condition 1).The genome:proteome landscape of TCR contains many distinct proteins that are functionally equivalent for the selection conditions of the thymus. Because thymic selection cannot distinguish between these neutral variants, this allows for the accumulation of a genetically diverse repertoire of receptors across the naïve T cell population (CGV condition 2). However, these TCRs retain functional differences that, while hidden in the initial selection context of the thymus, can lead to the expression of highly distinct cell responses (activation) when T cells are removed from their initial developmental environment and presented with antigens. Each novel (antigen) environment leads to the activation of a small unique subset of naïve T cells, which at the population level appears as a widening of the T cell population’s affinity distribution (Figure 1). The antigen-specific exposure of T cell affinity differences is an example of trait differences released under novel environmental conditions and is a hallmark of CGV (CGV condition 3). Antigen-specific T cell response differences have a clear genetic basis that is found in the variation of alpha and beta chains (CGV condition 4). Moreover, in a properly functioning immune system, the exposure of response differences leads to activation and subsequent clonal expansion for a small selected set of T cells, demonstrating the evolutionary relevance of this CGV. Defining characteristics of the innate and adaptive immune response in T cells thus correspond with defining characteristics of evolutionarily relevant CGV phenomena (summarized in Figure 2 and A Summary of CGV’s Role in T-cell Activation in Appendix). Together, these features formally establish a role for cryptic genetic variation in a well-defined evolving cell population.
Figure 2
Comparing attributes of T cells (cell development and activation) with CGV in natural populations. In both cases, genetic diversity arises in a stable environment that selects cells/organisms that fall within a narrow band of trait values. When exposed to a novel environment, trait differences are revealed in the population. In adaptive immunity, we consistently observe a subset of cells that are selected to undergo clonal expansion. In natural populations, a change in the environment does not always immediately reveal trait differences that are selectively relevant; however selection of sub-populations with selective advantage resulting from CGV is expected to take place over sufficiently long timescales.
Comparing attributes of T cells (cell development and activation) with CGV in natural populations. In both cases, genetic diversity arises in a stable environment that selects cells/organisms that fall within a narrow band of trait values. When exposed to a novel environment, trait differences are revealed in the population. In adaptive immunity, we consistently observe a subset of cells that are selected to undergo clonal expansion. In natural populations, a change in the environment does not always immediately reveal trait differences that are selectively relevant; however selection of sub-populations with selective advantage resulting from CGV is expected to take place over sufficiently long timescales.
An ideal experimental system
T cell adaptive immunity provides ideal genotypic, phenotypic, and environmental conditions that allow links between CGV and environment-induced adaptation to be clearly established. For one, the adaptive immune response preserves selected phenotypes (memory T cells) without continued stimulation from the environment and without the need for additional genetic accommodation. CGV can thus be isolated from future environmental changes and genetic changes that would continue to take place when CGV is revealed in natural populations such as genetic accommodation and drift.Adaptive immunity also has a well-characterized genetic basis with a small genetic footprint, despite T cell activation being a highly polygenic trait. Relevant genetic differences between T cells are constrained to a single TCR receptor with a genetic sequence that is highly constrained to a predefined space of recombined alpha/beta chains. TCR is generated through a stochastic recombination of gene segments. As a result of this recombination, each gene segment can contribute to activation differences in the T cell repertoire yet remains cryptic within a number of genetic backgrounds. This provides an important similarity to CGV in sexually reproducing populations without the presence of other features of sexual reproduction that would otherwise arise, such as linkage disequilibrium and assortative mating. Furthermore, with the immune system there is no need to isolate CGV from other causes of genetic diversity such as environmental heterogeneity or density dependent selection.The environmental changes that induce T cell responses are also well-characterized by changes in antigens attached to the surfaces of APCs. Because the time between infections is typically much longer than the immune response time (T cell activation and transition to long-lived memory cells), environmental volatility is not a confounding factor. In addition, environment-induced trait differences are nicely characterized by a digital on/off activation response.In contrast, evolution in natural populations proceeds through a concurrent stochastic population process where both standing genetic variation and de novo mutations contribute to adaptation, and where non-selective factors such as genetic drift and genetic hitchhiking also influence allele frequencies. Studying the contribution of CGV in evolution is also difficult because its role is typically revealed in a heterogeneous and dynamic environment where genetic assimilation (Schmalhausen and Dobzhansky, 1949; Waddington, 1953, 1957b) and genetic accommodation (West-Eberhard, 2003, 2005) are sometimes needed to preserve the inheritance of phenotypic adaptations in the face of ongoing environmental change (West-Eberhard, 2003; Pigliucci et al., 2006). By isolating CGV from these factors, T cell adaptive immunity provides an experimental system where the contribution of CGV toward rapid evolution of cellular phenotypes can be clearly established and confirmed.It is worth clarifying why we focus on adaptation in T cells and not B cells. The adaptive response in naive T cells arises from CGV exposure within a novel environment and does not involve a classic genetic search process where the onset of adaptation would take place by the discovery of a novel allele. The story is more complicated in B cells because adaptations can arise from both CGV and a genetic search process. In particular, after the environment-dependent activation of B cells, a genetic search occurs that involves clonal expansion, hyper-mutation, and selection, with the result being a more finely tuned memory B cell. Clearly both gene-induced and environment-induced adaptations are therefore relevant to the immune system. By focusing on T cells we remove any ambiguity as to the origins of adaptation and also in the subsequent proof of principles that were discussed.
Concluding Remarks
Evolution is traditionally characterized as a process involving incremental genetic changes that are discovered and fixed in a population through genetic drift and selection. While the genetic basis of heredity is not disputed, it is increasingly recognized that the introduction of novel alleles is not the only way that heritable phenotypes originate in species. A growing body of evidence suggests that changes in the environment induce heritable and evolutionarily relevant trait differences; revealing previously cryptic genetic diversity that drives rapid evolution (Schmalhausen and Dobzhansky, 1949; Waddington, 1953, 1957b; West-Eberhard, 2003, 2005; Gibson and Dworkin, 2004; Palmer, 2004; Barrett and Schluter, 2008; Schlichting, 2008).However, multiple confounding factors normally make it difficult to demonstrate the evolutionary significance of cryptic genetic variation (Barrett and Schluter, 2008; McGuigan and Sgrò, 2009). Evidence of environment-exposed CGV driving heritable changes in a deme is sporadic at best (McGuigan and Sgrò, 2009); it remains difficult to systematically uncover, and its plausibility is thus far only indirectly supported by the controlled manipulation of artificial environments (Barrett and Schluter, 2008; Hayden et al., 2011; McGuigan et al., 2011) or phylogenetic analysis (Palmer, 2004; Barrett and Schluter, 2008).In this article we have recounted how T cell maturation and antigen-specific activation provide a clear and unambiguous example of environmental exposure of cryptic genetic variation that drives complex phenotypic changes in a cell population. CGV within the TCR repertoire facilitates rapid evolutionary responses in the adaptive immune system and is fundamental to the survival of vertebrates in the face of infections from diverse pathogenic sources.Cryptic genetic variation-driven evolution may have broad repercussions to scientific research investigating the preservation of species and the eradication of evolvable pathogens. In conservation biology for instance, intraspecific genetic diversity is a well known factor in extinction risk. However, only genetic variants that produce trait differences under future environmental stresses can mitigate extinction risks. Quantifying G × E interactions for stresses that a species may encounter in the future, for instance by selecting stresses based on predictive models of regional climate change, should reveal biodiversity with the greatest significance for species conservation efforts. Moreover, with limited conservation budgets, strategies for preserving this much smaller CGV footprint may provide a more realistic and realizable conservation goal.On the other hand, in highly evolvable diseases such as aggressive cancers, the accumulation of CGV may contribute to the rapid evolution of therapy resistance that is seen in the latest generation of targeted therapies (Tian et al., 2011). Tumors with high genetic diversity have already been shown to more rapidly evolve resistance to therapies (Gerlinger and Swanton, 2010; Tian et al., 2011). Interestingly, the therapeutic strategies used today may inadvertently play to the strengths of evolvable cancers (Read et al., 2011). For instance, therapies are often applied long after therapy resistance is first established in the cancer cell population, thereby allowing a founder population to grow and acquire the genetic diversity needed for further adaptation to the next therapy that is eventually applied. If the therapy were instead changed at the point of lowest CGV, the cell population would be highly vulnerable to new environmental stresses in a manner analogous to the extinction risks posed by low genetic diversity in natural populations. CGV will not readily accumulate in a rapidly changing environment with strong directional selection and we propose therefore that dynamic therapeutic strategies could provide a new approach to reducing the evolutionary potential of cancers containing high levels of genetic diversity.Using an ideal model system, this paper formally establishes links between cryptic alleles and environment-induced adaptation in a complex cellular phenotype. As confirmation of these principles is further documented in other biological contexts and becomes more widely accepted, we anticipate that CGV will act as a focal point in efforts to preserve or eradicate evolving populations.
Conflict of Interest Statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Authors: Mark S Anderson; Emily S Venanzi; Ludger Klein; Zhibin Chen; Stuart P Berzins; Shannon J Turley; Harald von Boehmer; Roderick Bronson; Andrée Dierich; Christophe Benoist; Diane Mathis Journal: Science Date: 2002-10-10 Impact factor: 47.728